Although most individuals with a mild traumatic brain injury (mTBI) are symptom-free after 1-2 weeks, around 20% experience debilitating persistent post-concussion symptoms (PPCS) that last for several weeks or longer. A major challenge for clinicians is predicting the ~20% who will experience PPCS. Discovery of a prognostic biomarker for PPCS would allow clinicians to identify which patients require increased monitoring and interventions to improve recovery. In this study, in an ongoing collaboration with Prof. Biswadev Mitra, Director of Emergency Medicine Research at The Alfred, we will recruit mTBI and control patients through The Alfred Hospital Emergency Department, and investigate how novel blood tests might be used to predict patients with PPCS.
Concussion, biomarker, mild traumatic brain injury, neuropsychological testing, physiology, neuroscience, pathology
Central Clinical School » Neuroscience
Masters by research
Top-up scholarship funding available
Alfred Centre, The Alfred Hospital